Amrendra Tiwari Selected Research

Erlotinib Hydrochloride (CP 358,774)

12/2022

Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amrendra Tiwari Research Topics

Disease

1	Obesity 01/2023
1	Hyperlipidemias (Hyperlipidemia) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Hemolysis 12/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022

Drug/Important Bio-Agent (IBA)

1	LipidsIBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022
1	SolutionsIBA 12/2022
1	asolectinIBA 12/2022
1	ErbB Receptors (EGF Receptor)IBA 12/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2022
1	Ether (Diethyl Ether)IBA 12/2022

Therapy/Procedure

1	Ayurvedic Medicine (Siddha Medicine) 01/2023